Golden State Equity Partners Johnson & Johnson Transaction History

Golden State Equity Partners

$470 Million
Q2 2024

A detailed history of Golden State Equity Partners transactions in Johnson & Johnson stock. As of the latest transaction made, Golden State Equity Partners holds 14,926 shares of JNJ stock, worth $2.4 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

14,926

Previous 19,225 22.36%

Holding current value

$2.4 Million

Previous $3.01 Million 27.61%

% of portfolio

0.46%

Previous 0.75%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$144.38 - $157.78 $620,689 - $678,296	-4,299 Reduced 22.36%	14,926 $2.18 Million
Q4 2023 Feb 02, 2024	SELL	$145.6 - $158.88 $732,368 - $799,166	-5,030 Reduced 20.74%	19,225 $3.01 Million
Q3 2023 Oct 20, 2023	BUY	$155.75 - $174.48 $102,639 - $114,982	659 Added 2.79%	24,255 $3.78 Million
Q2 2023 Jul 19, 2023	SELL	$154.35 - $166.11 $310,860 - $334,545	-2,014 Reduced 7.86%	23,596 $3.91 Million
Q1 2023 Jun 01, 2023	BUY	$151.05 - $180.26 $1.21 Million - $1.45 Million	8,028 Added 45.66%	25,610 $3.97 Billion
Q1 2022 May 18, 2022	BUY	$158.14 - $179.59 $391,870 - $445,024	2,478 Added 16.41%	17,582 $3.12 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $726,969 - $825,575	-4,597 Reduced 23.33%	15,104 $2.48 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $373,608 - $414,531	-2,396 Reduced 10.84%	19,701 $3.37 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $485,469 - $539,486	3,006 Added 15.75%	22,097 $3.57 Million
Q2 2021 Aug 12, 2021	BUY	$159.48 - $171.07 $635,846 - $682,056	3,987 Added 26.4%	19,091 $3.15 Million
Q1 2021 May 13, 2021	BUY	$153.07 - $170.48 $220,573 - $245,661	1,441 Added 10.55%	15,104 $2.48 Million
Q4 2020 Feb 08, 2021	BUY	$137.11 - $157.38 $1.87 Million - $2.15 Million	13,663 New	13,663 $2.15 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $420B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.

Account

Golden State Equity Partners Johnson & Johnson Transaction History